Inner Cosmos recently reported interim 36-month outcomes from a study of its psychiatric brain-computer interface (BCI) ...

Atia Vision announced today that it received FDA investigational device exemption (IDE) approval to study its OmniVu lens ...

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

The study utilizes the Philips Azurion image-guided therapy system, which offers live X-ray imaging during percutaneous ...

A federal jury has ordered Johnson & Johnson's Biosense Webster business to pay $147 million to a cardiac mapping catheter ...

Merit Medical Systems (Nasdaq:MMSI) announced today that it acquired hemostatic device manufacturer Biolife Delaware.

The room-temperature collagen pad, approved for hemostasis and sealing, features an extended shelf life of three years. It involves the interaction of two components that can create rapid and lasting ...

Stryker announced today that it received FDA 510(k) clearance for its OptaBlate basivertebral nerve ablation system ...

Cordis today announced the initiation of a global registry to track real-world outcomes for the Selution SLR drug-eluting ...

Personal exoskeleton maker Lifeward (Nasdaq:LFWD) announced today that it appointed Mark Grant as its new president and CEO.

Apreo Health today announced first-in-human six-month clinical data supporting the use of its Breathe airway scaffold device.

Philips (NYSE: PHG) announced today that it launched its VeriSight Pro 3D intracardiac echocardiography (ICE) catheter in ...